Cargando…
Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common hematological malignancy. Although more than half of patients with DLBCL achieve long-term remission, the majority of remaining patients succumb to the disease. As abnormal iron homeostasis is implicated in carcinogenesis and the progression o...
Autores principales: | Devin, Julie, Cañeque, Tatiana, Lin, Yea-Lih, Mondoulet, Lucie, Veyrune, Jean-Luc, Abouladze, Matthieu, Garcia De Paco, Elvira, Karmous Gadacha, Ouissem, Cartron, Guillaume, Pasero, Philippe, Bret, Caroline, Rodriguez, Raphaël, Moreaux, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359736/ https://www.ncbi.nlm.nih.gov/pubmed/35078814 http://dx.doi.org/10.1158/0008-5472.CAN-21-0218 |
Ejemplares similares
-
Rapid Access to Ironomycin Derivatives by Click Chemistry
por: Antoszczak, Michał, et al.
Publicado: (2022) -
Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
por: Gourzones, Claire, et al.
Publicado: (2019) -
Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma
por: Herviou, Laurie, et al.
Publicado: (2021) -
Transcription/Replication Conflicts in Tumorigenesis and Their Potential Role as Novel Therapeutic Targets in Multiple Myeloma
por: Dutrieux, Laure, et al.
Publicado: (2021) -
Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy
por: Fernandez, Mario R., et al.
Publicado: (2022)